BOD Stock Overview
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bod Science Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.024 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.024 |
| Beta | 1.45 |
| 1 Month Change | 0% |
| 3 Month Change | -7.69% |
| 1 Year Change | -65.22% |
| 3 Year Change | -94.95% |
| 5 Year Change | -95.10% |
| Change since IPO | -91.72% |
Recent News & Updates
Shareholder Returns
| BOD | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.5% | 1.4% |
| 1Y | -65.2% | -5.5% | 9.2% |
Return vs Industry: BOD underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.
Return vs Market: BOD underperformed the Australian Market which returned 9.6% over the past year.
Price Volatility
| BOD volatility | |
|---|---|
| BOD Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.3% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: BOD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BOD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Jo Patterson | bodscience.com |
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets.
Bod Science Limited Fundamentals Summary
| BOD fundamental statistics | |
|---|---|
| Market cap | AU$4.26m |
| Earnings (TTM) | -AU$7.95m |
| Revenue (TTM) | AU$3.32m |
1.3x
P/S Ratio-0.5x
P/E RatioIs BOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOD income statement (TTM) | |
|---|---|
| Revenue | AU$3.32m |
| Cost of Revenue | AU$1.05m |
| Gross Profit | AU$2.27m |
| Other Expenses | AU$10.22m |
| Earnings | -AU$7.95m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.045 |
| Gross Margin | 68.40% |
| Net Profit Margin | -239.47% |
| Debt/Equity Ratio | -136.9% |
How did BOD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/20 07:50 |
| End of Day Share Price | 2023/11/23 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bod Science Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexander Smith | PAC Partners Securities Pty. Ltd. |